| TL;DR Mounjaro (tirzepatide) and Wegovy (semaglutide) are both highly effective weight loss treatments, but clinical trials consistently show that Mounjaro produces greater average weight loss at standard doses. However, individual results vary significantly based on genetics, diet, dose reached, and other health factors. The new Wegovy 7.2mg dose, approved in January 2026, now achieves comparable results to Mounjaro at its maximum. |
Not all weight loss treatments produce the same results for every person. Even within the same medication, patients on identical doses can experience vastly different outcomes. When comparing Mounjaro and Wegovy, this variability is compounded by the fact that the two drugs work through fundamentally different mechanisms.
Understanding why Mounjaro tends to produce greater weight loss on average is both scientifically interesting and practically important if you are considering starting or switching between these treatments.
Mounjaro vs Wegovy Weight Loss: The Fundamental Biological Difference
Wegovy (semaglutide) is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is a hormone your gut produces naturally after you eat. It signals to your brain that you are full, slows down how quickly food leaves your stomach (gastric emptying), and stimulates the pancreas to release insulin in response to rising blood glucose. Semaglutide mimics and amplifies this hormone, producing sustained appetite suppression over the course of a week from a single injection.
Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist. It does everything Wegovy does through the GLP-1 pathway, but it also activates the GIP (glucose-dependent insulinotropic polypeptide) receptor simultaneously. GIP is a separate gut hormone that plays a role in insulin secretion, fat metabolism, and energy balance. By activating both GLP-1 and GIP pathways together, tirzepatide creates a broader, more powerful metabolic signal.
Mounjaro vs Wegovy Effectiveness: Why Individual Results Vary So Widely
Both are effective, but results differ significantly between individuals
- Dose reached:
Higher doses deliver better results, but side effects may limit how far a patient can titrate
- Type 2 diabetes:
Patients without diabetes typically achieve greater weight loss than those with it
- Lifestyle habits:
Consistent diet and exercise improve outcomes; the medication enhances, not replaces, these changes
- Genetics:
Differences in receptor response mean some patients naturally respond better to one treatment than the other
- Starting weight:
Higher BMI often leads to greater weight loss in kilograms, though percentage loss is similar
- Other medications:
Certain drugs can reduce effectiveness by counteracting appetite suppression
Difference Between Mounjaro and Wegovy: Side Effects
Side effects are a key factor when choosing between Mounjaro and Wegovy, as tolerability affects adherence and outcomes
- Common side effects (both):
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Most noticeable during early dose escalation
- In the SURMOUNT-5 trial, Discontinuation due to side effects was lower with tirzepatide (2.7%)
- Individual response varies:
- Some patients tolerate Wegovy better
- Others find Mounjaro easier to manage
- No reliable way to predict tolerance in advance
- Important practical difference:
- Mounjaro may reduce the absorption of oral medications during dose increases
- This includes the combined oral contraceptive pill
- Additional contraceptive precautions are recommended for 4 weeks after each dose escalation
Mounjaro vs Wegovy UK: Which Should You Choose?
Wegovy may be more suitable if:
- Cost is a key factor (generally more affordable following recent pricing changes)
- You have established cardiovascular disease, with benefits supported by the SELECT trial
- You’ve previously responded well to semaglutide-based treatments like Ozempic
- You want the option of a higher-dose pathway (e.g. 7.2 mg) to approach similar efficacy at a lower overall cost
Mounjaro may be more suitable if:
- You want the highest likelihood of greater weight loss at standard doses
- You have not achieved adequate results with semaglutide-based treatments
- You have type 2 diabetes alongside obesity, where its dual mechanism may offer added metabolic benefits
- You prefer greater dosing flexibility, with six dose increments allowing more tailored titration
Is It Worth Switching From Wegovy to Mounjaro?
Switching between these medications is clinically common and can be done safely under medical supervision. Patients typically begin Mounjaro one week after their last Wegovy injection, starting at an appropriate dose as guided by their prescriber. The different active molecules mean that dose conversion is not straightforward, so a clinical review before switching is always required.
Reasons patients commonly switch include wanting greater weight loss after plateauing on Wegovy, experiencing intolerable side effects on one drug but not the other, or the new availability of Mounjaro on the NHS in their area, making it more accessible.
For a detailed breakdown of 2026 UK pricing for both treatments, our Wegovy vs Mounjaro 2026 UK guide covers current costs, NHS access, and what to expect from each treatment.
FAQs
Why do some people lose more weight on Wegovy than others?
Individual results depend on dose tolerated, genetics, diet quality, starting weight, and whether type 2 diabetes is present. Non-diabetic patients and those who reach the higher doses tend to achieve the greatest weight loss.
Why are people stopping Wegovy?
Common reasons include side effects (particularly nausea and vomiting), cost of ongoing private prescription, insufficient weight loss at tolerated doses, or switching to Mounjaro after learning about the SURMOUNT-5 trial results showing tirzepatide’s greater average efficacy.
Is it worth switching from Wegovy to Mounjaro?
For patients who have plateaued or not achieved their goal weight on Wegovy, switching under clinical supervision can be worthwhile. The dual mechanism of Mounjaro may produce additional results. A prescriber review is essential before any switch.
Does weight loss increase with higher doses of Wegovy?
Yes. Clinical trial data show a clear dose-response relationship: higher Wegovy doses produce greater average weight loss. The new 7.2mg dose produces approximately 20.7% weight loss, essentially matching Mounjaro 15mg, compared to 14.9% at the standard 2.4mg dose.